DRUG · Mapped RxNorm record
Darolutamide
Normalized identity: darolutamide View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
NCT04319783
Study summary
ClinicalTrials.govDarolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
RADIATION · Unmapped registry intervention
Radiotherapy
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Advanced Prostate Carcinomaunresolved
Cancer of Prostateunresolved
PSAunresolved
Castrate Resistant Prostate Cancerunresolved
Interventions
DarolutamideDRUG · verified · RxNorm: darolutamide
RadiotherapyRADIATION
Sponsors & collaborators
Trans Tasman Radiation Oncology Grouplead sponsor
Bayercollaborator
Peter MacCallum Cancer Centre, Australiacollaborator
Mapped research locations
SingaporeSingapore1MelbourneVictoria, Australia1AdelaideSouth Australia, Australia1DarlinghurstNew South Wales, Australia1Box HillVictoria, Australia1WoolloongabbaQueensland, Australia1HerstonQueensland, Australia1HobartTasmania, Australia1MurdochWestern Australia, Australia1WaratahNew South Wales, Australia1St AlbansVictoria, Australia1RichmondVictoria, Australia1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04319783 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.